| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $145,831,501 ) (Continued on the next page) |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG085545 | The role of sulfatide in the development of tauopathy in the context of ADRD | 000 | 1 | NIH | 9/16/2024 | $628,702 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG083865 | Vascular Imaging Biomarker Relationships to Alzheimer’s disease (VIBRA) | 000 | 1 | NIH | 9/16/2024 | $790,491 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 Floyd Curl Drive | San Antonio | TX | 78229-3901 | BEXAR | USA | T2253397 | Dental Reimbursement Program | 00 | 1 | HRSA | 7/29/2024 | $16,030 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | T2253397 | Dental Reimbursement Program | 01 | 1 | HRSA | 8/14/2024 | $0 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI045050 | Characterization of SLE-susceptibility loci on mouse chromosome 1 | 004 | 24 | NIH | 9/4/2024 | $57,932 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R61AT012117 | Development of a phenotypic screening assay for novel compounds that inhibit peripheral pain-sensing neurons | 002 | 2 | NIH | 7/18/2024 | $0 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35CA241801 | Mechanisms of DNA Homology-directed Genome Repair and Tumor Suppression | 001 | 6 | NIH | 7/31/2024 | $834,337 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R00GM140264 | Biochemical, structural and molecular dissection of androgen receptor transcriptional activity | 000 | 4 | NIH | 8/9/2024 | $12,562 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | T32TR004544 | CTSA Postdoctoral T32 at The University of Texas Health Science Center at San Antonio | 000 | 2 | NIH | 7/26/2024 | $275,194 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA262657 | Improving Therapeutic Approaches for RAS-driven Rhabdomyosarcoma | 002 | 3 | NIH | 8/29/2024 | -$195,227 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R00GM140264 | Biochemical, structural and molecular dissection of androgen receptor transcriptional activity | 002 | 5 | NIH | 8/29/2024 | $75,375 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK024092 | SGLT2 Inhibitors, Ketogenesis, and Ketoacidosis | 000 | 39 | NIH | 7/12/2024 | $647,274 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE026769 | Enamel with overexpressed ameloblastin | 001 | 7 | NIH | 8/13/2024 | $349,370 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R00GM140264 | Biochemical, structural and molecular dissection of androgen receptor transcriptional activity | 001 | 5 | NIH | 8/12/2024 | $248,999 |
| | 2024 | 2024 | UNI OF TX HEALTH SCIENCE CTR SAN ANT | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R61AT012117 | Development of a phenotypic screening assay for novel compounds that inhibit peripheral pain-sensing neurons | 000 | 2 | NIH | 1/29/2024 | $380,522 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA262657 | Improving Therapeutic Approaches for RAS-driven Rhabdomyosarcoma | 001 | 3 | NIH | 4/17/2024 | $17,729 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA172408 | Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies | 001 | 11 | NIH | 4/16/2024 | $24,927 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R37CA262657 | Improving Therapeutic Approaches for RAS-driven Rhabdomyosarcoma | 000 | 3 | NIH | 1/22/2024 | $319,106 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA172408 | Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies | 000 | 11 | NIH | 12/22/2023 | $448,684 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK109560 | Bacteria-associated VB12 regulates neonatal ileal epithelium homeostasis | 000 | 10 | NIH | 7/23/2024 | $334,801 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R00DE031784 | Specialized Proresolving Lipid Mediator-Enhanced Stem Cell Therapy and Tissue Regeneration | 000 | 3 | NIH | 9/23/2024 | $248,993 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG018016 | The Mexican Health Aging Study (MHAS) | 009 | 18 | NIH | 7/31/2024 | $1,298,898 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG018016 | The Mexican Health Aging Study (MHAS) | 006 | 18 | NIH | 7/3/2024 | $0 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG018016 | The Mexican Health Aging Study (MHAS) | 005 | 18 | NIH | 6/4/2024 | $1,694,384 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA055703 | Uptake2 transporters: Novel sex-dependent molecular targets to treat stimulant use disorder | 000 | 2 | NIH | 5/22/2024 | $680,812 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA060215 | Behavioral Pharmacology of Opioid/Xylazine Mixtures | 001 | 1 | NIH | 9/11/2024 | $0 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI151638 | Novel Translational Control Mechanisms in Host Range Restriction of Poxvirus | 000 | 5 | NIH | 7/24/2024 | $422,396 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DA060215 | Behavioral Pharmacology of Opioid/Xylazine Mixtures | 000 | 1 | NIH | 9/10/2024 | $392,940 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI148641 | Development of a rapid, pan fungal diagnostic assay | 000 | 4 | NIH | 1/18/2024 | $407,215 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R13CA287954 | Advancing the Science of Cancer in Latinos 2024 | 000 | 1 | NIH | 2/20/2024 | $10,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01EY012085 | Intercellular Communication in the Eye Lens | 002 | 26 | NIH | 1/10/2024 | $433,022 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM140127 | An Integrated Biochemical and Structural Approach to Delineating the Biology of EWSR1 | 000 | 4 | NIH | 6/21/2024 | $325,500 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI148641 | Development of a rapid, pan fungal diagnostic assay | 001 | 4 | NIH | 6/6/2024 | $45,246 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 Floyd Curl Drive | San Antonio | TX | 78229-3901 | BEXAR | USA | G2846309 | Rural Communities Opioid Response Program ? Mental and Behavioral Health | 00 | 3 | HRSA | 7/17/2024 | $500,000 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UG1CA189855 | Texas Pediatric NCORP MU | 000 | 11 | NIH | 8/1/2024 | $926,379 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI173816 | Novel animal models to study organ-specific SARS-CoV-2-induced pathology | 001 | 2 | NIH | 5/10/2024 | $22,062 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 Floyd Curl Drive | San Antonio | TX | 78229-3901 | BEXAR | USA | T0830150 | Scholarships for Disadvantaged Students | 01 | 9 | HRSA | 8/8/2024 | $20,000 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG075703 | Epidemiology of blood pressure responses to perturbations: Correlates and prognosis for vascular risk, end-organ damage, cognitive aging and preclinical Alzheimer's disease | 000 | 3 | NIH | 3/14/2024 | $582,280 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | T0830150 | Scholarships for Disadvantaged Students | 00 | 9 | HRSA | 5/24/2024 | $650,000 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA293655 | Structure and function of RAD51 paralog tumor suppressor complexes in genome maintenance | 000 | 1 | NIH | 5/13/2024 | $669,325 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM127006 | Double strand break repair maelstrom: causes, mechanisms and genome destabilizing consequences | 004 | 7 | NIH | 9/27/2024 | $8,195 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG075703 | Epidemiology of blood pressure responses to perturbations: Correlates and prognosis for vascular risk, end-organ damage, cognitive aging and preclinical Alzheimer's disease | 001 | 3 | NIH | 6/28/2024 | $64,697 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | T32TR004545 | CTSA Predoctoral T32 at The University of Texas Health Science Center at San Antonio | 000 | 2 | NIH | 7/19/2024 | $274,584 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM127006 | Double strand break repair maelstrom: causes, mechanisms and genome destabilizing consequences | 001 | 7 | NIH | 7/16/2024 | $458,325 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30MH134482 | Identifying a critical developmental period for cognitive speed in a mouse model for neurodevelopmental disorders | 001 | 1 | NIH | 3/11/2024 | $0 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30MH134482 | Identifying a critical developmental period for cognitive speed in a mouse model for neurodevelopmental disorders | 000 | 1 | NIH | 3/11/2024 | $40,231 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA257148 | Lineage Plasticity, due to Disruption of MnSOD Biology, drives resistance to Ionizing Radiation / Androgen Deprivation Therapy | 000 | 4 | NIH | 2/22/2024 | $345,411 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI173816 | Novel animal models to study organ-specific SARS-CoV-2-induced pathology | 000 | 2 | NIH | 11/8/2023 | $198,563 |
| | 2024 | 2024 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM140084 | METTL3-NUP93 interaction facilitates the nuclear export of m6A-modified mRNAs | 000 | 4 | NIH | 7/2/2024 | $328,634 |
|
